vimarsana.com

Latest Breaking News On - Timessquare capital management - Page 2 : vimarsana.com

Nicholas Company Inc. Acquires 23,195 Shares of AtriCure, Inc. (NASDAQ:ATRC)

Nicholas Company Inc. lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 15.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 170,820 shares of the medical device company’s stock after purchasing an additional 23,195 shares during the quarter. Nicholas […]

United-states
New-jersey
Karls-dahlquist
Salvatore-privitera
Stifel-nicolaus
Securities-exchange-commission
Canaccord-genuity-group
Columbus-asset-advisors
Needham-company
Timessquare-capital-management
Jersey-common-pension-fund
Atricure-inc

Embraer (NYSE:ERJ) Rating Lowered to Hold at StockNews.com

Embraer (NYSE:ERJ – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday. Other equities analysts have also issued research reports about the stock. Morgan Stanley lifted their price target on shares of Embraer from $19.50 […]

United-states
Canada
Brazil
America
Asia-pacific
Jpmorgan-chase-co
Itau-unibanco-holding
Embraer-company-profile
Jennison-associates
Simplicity-wealth
Embraer
Goldman-sachs-group

Is Krystal Biotech, Inc. (NASDAQ:KRYS) the Premier Gene Therapy Stock for Your Portfolio?

We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Krystal Biotech, Inc.

United-states
America
Cathie-wood
Nasdaq
Krystal-biotech-inc
Number-of-hedge-fund-holders
Nvidia
Gene-therapy-stocks
Buy-now
Krystal-biotech
North-america
Premier-gene-therapy-stock

ICF International, Inc. (NASDAQ:ICFI) Short Interest Update

ICF International, Inc. (NASDAQ:ICFI – Get Free Report) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 171,400 shares, a decline of 10.3% from the April 30th total of 191,000 shares. Based on an average daily trading volume, of 84,400 […]

United-states
International-daily
Timessquare-capital-management
Icf-international-inc
Barrington-research
Point-inc
International-inc
International-announces-dividend
Neumeier-poma-investment-counsel
Nasdaq
Canaccord-genuity-group

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Director Purchases $253,500.00 in Stock

Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) Director James T. Treace acquired 50,000 shares of Treace Medical Concepts stock in a transaction dated Tuesday, May 28th. The stock was purchased at an average price of $5.07 per share, with a total value of $253,500.00. Following the completion of the purchase, the director now […]

United-states
Stifel-nicolaus
Jamest-treace
Treace-medical-concepts-inc
Quest-partners
Treace-medical-concepts-company-profile
Timessquare-capital-management
Gabelli-funds
Walleye-capital
Nasdaq
Qube-research-technologies-ltd
Jpmorgan-chase-co

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.